title: MS patient 600155.0001, follow-up year 1 visit

description:
600155.0001B.CEL
whole blood of Interferon treated MS patient, sample 600155.0001B, Interferon Analysis, replication data set


title: MS patient 600155.0001, follow-up year 2 visit

status: Public on Jun 17 2013

type: RNA

city: San Francisco

first: Sergio

middle: E

last: Baranzini

state: CA

address: 675 Nelson Rising Lane, Room S-215

department: Neurology

country: USA

institute: University of California San Francisco

description:
600155.0001C.CEL
whole blood of Interferon treated MS patient, sample 600155.0001C, Interferon Analysis, replication data set

hyb_protocol: 5.5ug of ssDNA was fragmented before hybridization using the Affymetrix GeneChip Hybridization, Wash and Stain Kit.

scan_protocol: Microarrays were scanned using the Affymetrix GeneChip Scanner 3000 7G.

data_processing:
Microarray data were processed in R using the R package aroma.affymetrix. Data were background corrected (RMAbackgroundCorrection) and quantile normalized before core probe sets were summarized to transcript level, using a custom made cdf file. This cdf file excludes all probes known to span single nucleotide polymorphisms (SNPs), which could interfere with hybridization and thus introduce noise (Duan, S., Zhang, W., Bleibel, W.K., Cox, N.J. and Dolan, M.E. (2008) SNPinProbe_1.0: a database for filtering out probes in the Affymetrix GeneChip human exon 1.0 ST array potentially affected by SNPs. Bioinformation, 2, 469-470).
probe group file: HuEx-1_0-st-v2,core,na31,hg19,HB20110919,noSNPs.cdf
meta-probeset file: HuEx-1_0-st-v2,core,na31,hg19,HB20110919,noSNPs.cdf

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: MS patient_Interferon_follow-up year 2

label_protocol: 1ug of total RNA that had been put through the ribo minus protocol was labelled using the Affymetrix GeneChip WT Sense Target Labeling and Control Reagent kit.

extract_protocol: Blood was drawn into PAXgene collection tubes and RNA was isolated using the PAXgene Blood RNA kit (Qiagen, Valencia, CA), following manufacturer’s instructions except for an additional washing step before RNA elution. DNA was digested on columns using the RNase-free DNase Set (Qiagen, Valencia, CA).

tag: ID

tag: gender

value: male

tag: disease

value: multiple sclerosis

tag: visit

value: follow-up year 2

tag: tissue

value: Interferon - Avonex

tag: treatment

value: whole blood

tag: data set

value: replication


title: MS patient 600148.0001, follow-up year 2 visit

description:
600148.0001C.CEL
whole blood of Interferon treated MS patient, sample 600148.0001C, Interferon Analysis, replication data set

value: female


title: MS patient 41532.0001, Baseline visit

description:
41532.0001A.CEL
whole blood of Interferon treated MS patient, sample 41532.0001A, Interferon Analysis, replication data set

source_name: MS patient_Interferon_Baseline

value: Baseline

value: Interferon - Betaseron


title: MS patient 600148.0001, follow-up year 1 visit

description:
600148.0001B.CEL
whole blood of Interferon treated MS patient, sample 600148.0001B, Interferon Analysis, replication data set

source_name: MS patient_Interferon_follow-up year 1

value: follow-up year 1


title: MS patient 600121.0001, follow-up year 2 visit

description:
600121.0001C.CEL
whole blood of Interferon treated MS patient, sample 600121.0001C, Interferon Analysis, replication data set


title: MS patient 600122.0001, follow-up year 1 visit

description:
600122.0001B.CEL
whole blood of Interferon treated MS patient, sample 600122.0001B, Interferon Analysis, replication data set


title: MS patient 41532.0001, follow-up year 2 visit

description:
41532.0001C.CEL
whole blood of Interferon treated MS patient, sample 41532.0001C, Interferon Analysis, replication data set


title: MS patient 40186.0001, Baseline visit

description:
40186.0001A.CEL
whole blood of Interferon treated MS patient, sample 40186.0001A, Interferon Analysis, replication data set

value: Interferon - Rebif


title: MS patient 600362.0001, follow-up year 1 visit

description:
600362.0001B.CEL
whole blood of Interferon treated MS patient, sample 600362.0001B, Interferon Analysis, replication data set


title: MS patient 600388.0001, follow-up year 1 visit

description:
600388.0001B.CEL
whole blood of Interferon treated MS patient, sample 600388.0001B, Interferon Analysis, replication data set


title: MS patient 600148.0001, Baseline visit

description:
600148.0001A.CEL
whole blood of Interferon treated MS patient, sample 600148.0001A, Interferon Analysis, replication data set


title: MS patient 600100.0001, follow-up year 2 visit

description:
600100.0001C.CEL
whole blood of Interferon treated MS patient, sample 600100.0001C, Interferon Analysis, replication data set


title: MS patient 600121.0001, Baseline visit

description:
600121.0001A.CEL
whole blood of Interferon treated MS patient, sample 600121.0001A, Interferon Analysis, replication data set


title: MS patient 41506.0001, follow-up year 2 visit

description:
41506.0001C.CEL
whole blood of Interferon treated MS patient, sample 41506.0001C, Interferon Analysis, replication data set


title: MS patient 41532.0001, follow-up year 1 visit

description:
41532.0001B.CEL
whole blood of Interferon treated MS patient, sample 41532.0001B, Interferon Analysis, replication data set


title: MS patient 600100.0001, Baseline visit

description:
600100.0001A.CEL
whole blood of Interferon treated MS patient, sample 600100.0001A, Interferon Analysis, replication data set


title: MS patient 41212.0001, follow-up year 1 visit

description:
41212.0001B.CEL
whole blood of Interferon treated MS patient, sample 41212.0001B, Interferon Analysis, replication data set


title: MS patient 41506.0001, follow-up year 1 visit

description:
41506.0001B.CEL
whole blood of Interferon treated MS patient, sample 41506.0001B, Interferon Analysis, replication data set


title: MS patient 41834.0001, follow-up year 2 visit

description:
41834.0001C.CEL
whole blood of Interferon treated MS patient, sample 41834.0001C, Interferon Analysis, replication data set


title: MS patient 600100.0001, follow-up year 1 visit

description:
600100.0001B.CEL
whole blood of Interferon treated MS patient, sample 600100.0001B, Interferon Analysis, replication data set


title: MS patient 600089.0001, follow-up year 1 visit

description:
600089.0001B.CEL
whole blood of Interferon treated MS patient, sample 600089.0001B, Interferon Analysis, replication data set


title: MS patient 600089.0001, follow-up year 2 visit

description:
600089.0001C.CEL
whole blood of Interferon treated MS patient, sample 600089.0001C, Interferon Analysis, replication data set


title: MS patient 600122.0001, follow-up year 2 visit

description:
600122.0001C.CEL
whole blood of Interferon treated MS patient, sample 600122.0001C, Interferon Analysis, replication data set


title: MS patient 41212.0001, follow-up year 2 visit

description:
41212.0001C.CEL
whole blood of Interferon treated MS patient, sample 41212.0001C, Interferon Analysis, replication data set


title: MS patient 41504.0001, follow-up year 2 visit

description:
41504.0001C.CEL
whole blood of Interferon treated MS patient, sample 41504.0001C, Interferon Analysis, replication data set


title: MS patient 600085.0001, follow-up year 1 visit

description:
600085.0001B.CEL
whole blood of Interferon treated MS patient, sample 600085.0001B, Interferon Analysis, replication data set


title: MS patient 600085.0001, Baseline visit

description:
600085.0001A.CEL
whole blood of Interferon treated MS patient, sample 600085.0001A, Interferon Analysis, replication data set


title: MS patient 600122.0001, Baseline visit

description:
600122.0001A.CEL
whole blood of Interferon treated MS patient, sample 600122.0001A, Interferon Analysis, replication data set


title: MS patient 600079.0001, follow-up year 1 visit

description:
600079.0001B.CEL
whole blood of Interferon treated MS patient, sample 600079.0001B, Interferon Analysis, replication data set


title: MS patient 41504.0001, follow-up year 1 visit

description:
41504.0001B.CEL
whole blood of Interferon treated MS patient, sample 41504.0001B, Interferon Analysis, replication data set


title: MS patient 41503.0001, follow-up year 2 visit

description:
41503.0001C.CEL
whole blood of Interferon treated MS patient, sample 41503.0001C, Interferon Analysis, replication data set


title: MS patient 600076.0001, follow-up year 2 visit

description:
600076.0001C.CEL
whole blood of untreated MS patient, sample 600076.0001C, Interferon Analysis, replication data set

source_name: MS patient_untreated_follow-up year 2

value: untreated


title: MS patient 600089.0001, Baseline visit

description:
600089.0001A.CEL
whole blood of untreated MS patient, sample 600089.0001A, Interferon Analysis, replication data set

source_name: MS patient_untreated_Baseline


title: MS patient 600079.0001, Baseline visit

description:
600079.0001A.CEL
whole blood of Interferon treated MS patient, sample 600079.0001A, Interferon Analysis, replication data set


title: MS patient 600076.0001, Baseline visit

description:
600076.0001A.CEL
whole blood of Interferon treated MS patient, sample 600076.0001A, Interferon Analysis, replication data set


title: MS patient 600064.0001, follow-up year 2 visit

description:
600064.0001C.CEL
whole blood of Interferon treated MS patient, sample 600064.0001C, Interferon Analysis, replication data set


title: MS patient 600064.0001, follow-up year 1 visit

description:
600064.0001B.CEL
whole blood of Interferon treated MS patient, sample 600064.0001B, Interferon Analysis, replication data set


title: MS patient 600064.0001, Baseline visit

description:
600064.0001A.CEL
whole blood of Interferon treated MS patient, sample 600064.0001A, Interferon Analysis, replication data set


title: MS patient 600062.0001, follow-up year 2 visit

description:
600062.0001C.CEL
whole blood of Interferon treated MS patient, sample 600062.0001C, Interferon Analysis, replication data set


title: MS patient 41495.0001, Baseline visit

description:
41495.0001A.CEL
whole blood of untreated MS patient, sample 41495.0001A, Interferon Analysis, replication data set


title: MS patient 41256.0001, follow-up year 2 visit

description:
41256.0001C.CEL
whole blood of Interferon treated MS patient, sample 41256.0001C, Interferon Analysis, replication data set


title: MS patient 600044.0001, follow-up year 2 visit

description:
600044.0001C.CEL
whole blood of Interferon treated MS patient, sample 600044.0001C, Interferon Analysis, replication data set


title: MS patient 600044.0001, follow-up year 1 visit

description:
600044.0001B.CEL
whole blood of Interferon treated MS patient, sample 600044.0001B, Interferon Analysis, replication data set


title: MS patient 41495.0001, follow-up year 2 visit

description:
41495.0001C.CEL
whole blood of untreated MS patient, sample 41495.0001C, Interferon Analysis, replication data set


title: MS patient 41468.0001, follow-up year 1 visit

description:
41468.0001B.CEL
whole blood of Interferon treated MS patient, sample 41468.0001B, Interferon Analysis, replication data set


title: MS patient 600044.0001, Baseline visit

description:
600044.0001A.CEL
whole blood of Interferon treated MS patient, sample 600044.0001A, Interferon Analysis, replication data set


title: MS patient 41495.0001, follow-up year 1 visit

description:
41495.0001B.CEL
whole blood of untreated MS patient, sample 41495.0001B, Interferon Analysis, replication data set

source_name: MS patient_untreated_follow-up year 1


title: MS patient 600028.0001, Baseline visit

description:
600028.0001A.CEL
whole blood of Interferon treated MS patient, sample 600028.0001A, Interferon Analysis, replication data set


title: MS patient 600001.0001, Baseline visit

description:
600001.0001A.CEL
whole blood of untreated MS patient, sample 600001.0001A, Interferon Analysis, replication data set


title: MS patient 600028.0001, follow-up year 2 visit

description:
600028.0001C.CEL
whole blood of Interferon treated MS patient, sample 600028.0001C, Interferon Analysis, replication data set


title: MS patient 41468.0001, follow-up year 2 visit

description:
41468.0001C.CEL
whole blood of Interferon treated MS patient, sample 41468.0001C, Interferon Analysis, replication data set


title: MS patient 600511.0001, follow-up year 2 visit

description:
600511.0001C.CEL
whole blood of Interferon treated MS patient, sample 600511.0001C, Interferon Analysis, discovery data set

data_processing:
Microarray data were processed in R using the R package “aroma.affymetrix”. Data were background corrected (RMAbackgroundCorrection) and quantile normalized before core probe sets were summarized to transcript level, using a custom made cdf file. This cdf file excludes all probes known to span single nucleotide polymorphisms (SNPs), which could interfere with hybridization and thus introduce noise (Duan, S., Zhang, W., Bleibel, W.K., Cox, N.J. and Dolan, M.E. (2008) SNPinProbe_1.0: a database for filtering out probes in the Affymetrix GeneChip human exon 1.0 ST array potentially affected by SNPs. Bioinformation, 2, 469-470).
probe group file/meta-probeset file;
HuEx-1_0-st-v2,core,na31,hg19,HB20110919,noSNPs.cdf

value: discovery


title: MS patient 600483.0001, follow-up year 1 visit

description:
600483.0001B.CEL
whole blood of Interferon treated MS patient, sample 600483.0001B, Interferon Analysis, discovery data set


title: MS patient 600511.0001, follow-up year 1 visit

description:
600511.0001B.CEL
whole blood of Interferon treated MS patient, sample 600511.0001B, Interferon Analysis, discovery data set


title: MS patient 600001.0001, follow-up year 1 visit

description:
600001.0001B.CEL
whole blood of untreated MS patient, sample 600001.0001B, Interferon Analysis, replication data set


title: MS patient 41671.0001, Baseline visit

description:
41671.0001A.CEL
whole blood of untreated MS patient, sample 41671.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41671.0001, follow-up year 1 visit

description:
41671.0001B.CEL
whole blood of untreated MS patient, sample 41671.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600469.0001, follow-up year 2 visit

description:
600469.0001C.CEL
whole blood of untreated MS patient, sample 600469.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41671.0001, follow-up year 2 visit

description:
41671.0001C.CEL
whole blood of untreated MS patient, sample 41671.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600457.0001, follow-up year 2 visit

description:
600457.0001C.CEL
whole blood of untreated MS patient, sample 600457.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600469.0001, Baseline visit

description:
600469.0001A.CEL
whole blood of untreated MS patient, sample 600469.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600511.0001, Baseline visit

description:
600511.0001A.CEL
whole blood of Interferon treated MS patient, sample 600511.0001A, Interferon Analysis, discovery data set


title: MS patient 600457.0001, follow-up year 1 visit

description:
600457.0001B.CEL
whole blood of untreated MS patient, sample 600457.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600483.0001, follow-up year 2 visit

description:
600483.0001C.CEL
whole blood of Interferon treated MS patient, sample 600483.0001C, Interferon Analysis, discovery data set


title: MS patient 40061.0001, follow-up year 1 visit

description:
40061.0001B.CEL
whole blood of untreated MS patient, sample 40061.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 40061.0001, follow-up year 2 visit

description:
40061.0001C.CEL
whole blood of untreated MS patient, sample 40061.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 40061.0001, Baseline visit

description:
40061.0001A.CEL
whole blood of untreated MS patient, sample 40061.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41829.0001, follow-up year 1 visit

description:
41829.0001B.CEL
whole blood of Interferon treated MS patient, sample 41829.0001B, Interferon Analysis, discovery data set


title: MS patient 41829.0001, follow-up year 2 visit

description:
41829.0001C.CEL
whole blood of Interferon treated MS patient, sample 41829.0001C, Interferon Analysis, discovery data set


title: MS patient 41829.0001, Baseline visit

description:
41829.0001A.CEL
whole blood of untreated MS patient, sample 41829.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600441.0001, follow-up year 1 visit

description:
600441.0001B.CEL
whole blood of untreated MS patient, sample 600441.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600429.0001, follow-up year 1 visit

description:
600429.0001B.CEL
whole blood of Interferon treated MS patient, sample 600429.0001B, Interferon Analysis, discovery data set


title: MS patient 600435.0001, Baseline visit

description:
600435.0001A.CEL
whole blood of Interferon treated MS patient, sample 600435.0001A, Interferon Analysis, discovery data set


title: MS patient 600457.0001, Baseline visit

description:
600457.0001A.CEL
whole blood of untreated MS patient, sample 600457.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600435.0001, follow-up year 2 visit

description:
600435.0001C.CEL
whole blood of Interferon treated MS patient, sample 600435.0001C, Interferon Analysis, discovery data set


title: MS patient 600441.0001, follow-up year 2 visit

description:
600441.0001C.CEL
whole blood of untreated MS patient, sample 600441.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41655.0001, follow-up year 2 visit

description:
41655.0001C.CEL
whole blood of untreated MS patient, sample 41655.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600441.0001, Baseline visit

description:
600441.0001A.CEL
whole blood of untreated MS patient, sample 600441.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41655.0001, Baseline visit

description:
41655.0001A.CEL
whole blood of untreated MS patient, sample 41655.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41826.0001, Baseline visit

description:
41826.0001A.CEL
whole blood of untreated MS patient, sample 41826.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600429.0001, Baseline visit

description:
600429.0001A.CEL
whole blood of Interferon treated MS patient, sample 600429.0001A, Interferon Analysis, discovery data set


title: MS patient 41655.0001, follow-up year 1 visit

description:
41655.0001B.CEL
whole blood of untreated MS patient, sample 41655.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600435.0001, follow-up year 1 visit

description:
600435.0001B.CEL
whole blood of Interferon treated MS patient, sample 600435.0001B, Interferon Analysis, discovery data set


title: MS patient 41638.0001, follow-up year 1 visit

description:
41638.0001B.CEL
whole blood of Interferon treated MS patient, sample 41638.0001B, Interferon Analysis, discovery data set


title: MS patient 41826.0001, follow-up year 1 visit

description:
41826.0001B.CEL
whole blood of untreated MS patient, sample 41826.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41277.0001, follow-up year 2 visit

description:
41277.0001C.CEL
whole blood of Interferon treated MS patient, sample 41277.0001C, Interferon Analysis, discovery data set


title: MS patient 41826.0001, follow-up year 2 visit

description:
41826.0001C.CEL
whole blood of untreated MS patient, sample 41826.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41638.0001, Baseline visit

description:
41638.0001A.CEL
whole blood of Interferon treated MS patient, sample 41638.0001A, Interferon Analysis, discovery data set


title: MS patient 41277.0001, follow-up year 1 visit

description:
41277.0001B.CEL
whole blood of Interferon treated MS patient, sample 41277.0001B, Interferon Analysis, discovery data set


title: MS patient 41638.0001, follow-up year 2 visit

description:
41638.0001C.CEL
whole blood of Interferon treated MS patient, sample 41638.0001C, Interferon Analysis, discovery data set


title: MS patient 600394.0001, follow-up year 1 visit

description:
600394.0001B.CEL
whole blood of Interferon treated MS patient, sample 600394.0001B, Interferon Analysis, discovery data set


title: MS patient 41277.0001, Baseline visit

description:
41277.0001A.CEL
whole blood of Interferon treated MS patient, sample 41277.0001A, Interferon Analysis, discovery data set


title: MS patient 600392.0001, follow-up year 2 visit

description:
600392.0001C.CEL
whole blood of untreated MS patient, sample 600392.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600394.0001, Baseline visit

description:
600394.0001A.CEL
whole blood of Interferon treated MS patient, sample 600394.0001A, Interferon Analysis, discovery data set


title: MS patient 41654.0001, follow-up year 1 visit

description:
41654.0001B.CEL
whole blood of untreated MS patient, sample 41654.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41654.0001, Baseline visit

description:
41654.0001A.CEL
whole blood of untreated MS patient, sample 41654.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600394.0001, follow-up year 2 visit

description:
600394.0001C.CEL
whole blood of Interferon treated MS patient, sample 600394.0001C, Interferon Analysis, discovery data set


title: MS patient 600391.0001, follow-up year 1 visit

description:
600391.0001B.CEL
whole blood of untreated MS patient, sample 600391.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600392.0001, Baseline visit

description:
600392.0001A.CEL
whole blood of untreated MS patient, sample 600392.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600391.0001, Baseline visit

description:
600391.0001A.CEL
whole blood of untreated MS patient, sample 600391.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600390.0001, follow-up year 1 visit

description:
600390.0001B.CEL
whole blood of Interferon treated MS patient, sample 600390.0001B, Interferon Analysis, discovery data set


title: MS patient 600390.0001, Baseline visit

description:
600390.0001A.CEL
whole blood of Interferon treated MS patient, sample 600390.0001A, Interferon Analysis, discovery data set


title: MS patient 610043.0001, follow-up year 2 visit

description:
610043.0001C.CEL
whole blood of Interferon treated MS patient, sample 610043.0001C, Interferon Analysis, discovery data set


title: MS patient 41165.0001, follow-up year 1 visit

description:
41165.0001B.CEL
whole blood of untreated MS patient, sample 41165.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41165.0001, follow-up year 2 visit

description:
41165.0001C.CEL
whole blood of Interferon treated MS patient, sample 41165.0001C, Interferon Analysis, discovery data set


title: MS patient 600361.0001, follow-up year 2 visit

description:
600361.0001C.CEL
whole blood of Interferon treated MS patient, sample 600361.0001C, Interferon Analysis, discovery data set


title: MS patient 600361.0001, follow-up year 1 visit

description:
600361.0001B.CEL
whole blood of Interferon treated MS patient, sample 600361.0001B, Interferon Analysis, discovery data set


title: MS patient 600361.0001, Baseline visit

description:
600361.0001A.CEL
whole blood of Interferon treated MS patient, sample 600361.0001A, Interferon Analysis, discovery data set


title: MS patient 600360.0001, follow-up year 2 visit

description:
600360.0001C.CEL
whole blood of untreated MS patient, sample 600360.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 610043.0001, follow-up year 1 visit

description:
610043.0001B.CEL
whole blood of Interferon treated MS patient, sample 610043.0001B, Interferon Analysis, discovery data set


title: MS patient 41165.0001, Baseline visit

description:
41165.0001A.CEL
whole blood of untreated MS patient, sample 41165.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41616.0001, follow-up year 1 visit

description:
41616.0001B.CEL
whole blood of untreated MS patient, sample 41616.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600391.0001, follow-up year 2 visit

description:
600391.0001C.CEL
whole blood of untreated MS patient, sample 600391.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600392.0001, follow-up year 1 visit

description:
600392.0001B.CEL
whole blood of untreated MS patient, sample 600392.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41626.0001, follow-up year 1 visit

description:
41626.0001B.CEL
whole blood of untreated MS patient, sample 41626.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41626.0001, follow-up year 2 visit

description:
41626.0001C.CEL
whole blood of untreated MS patient, sample 41626.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 610043.0001, Baseline visit

description:
610043.0001A.CEL
whole blood of Interferon treated MS patient, sample 610043.0001A, Interferon Analysis, discovery data set


title: MS patient 600354.0001, follow-up year 2 visit

description:
600354.0001C.CEL
whole blood of Interferon treated MS patient, sample 600354.0001C, Interferon Analysis, discovery data set


title: MS patient 600354.0001, follow-up year 1 visit

description:
600354.0001B.CEL
whole blood of Interferon treated MS patient, sample 600354.0001B, Interferon Analysis, discovery data set


title: MS patient 600360.0001, Baseline visit

description:
600360.0001A.CEL
whole blood of untreated MS patient, sample 600360.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41626.0001, Baseline visit

description:
41626.0001A.CEL
whole blood of untreated MS patient, sample 41626.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600360.0001, follow-up year 1 visit

description:
600360.0001B.CEL
whole blood of untreated MS patient, sample 600360.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41815.0001, follow-up year 2 visit

description:
41815.0001C.CEL
whole blood of Interferon treated MS patient, sample 41815.0001C, Interferon Analysis, discovery data set


title: MS patient 600338.0001, follow-up year 2 visit

description:
600338.0001C.CEL
whole blood of Interferon treated MS patient, sample 600338.0001C, Interferon Analysis, discovery data set


title: MS patient 600338.0001, Baseline visit

description:
600338.0001A.CEL
whole blood of Interferon treated MS patient, sample 600338.0001A, Interferon Analysis, discovery data set


title: MS patient 41262.0001, Baseline visit

description:
41262.0001A.CEL
whole blood of Interferon treated MS patient, sample 41262.0001A, Interferon Analysis, discovery data set


title: MS patient 600337.0001, Baseline visit

description:
600337.0001A.CEL
whole blood of untreated MS patient, sample 600337.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41262.0001, follow-up year 1 visit

description:
41262.0001B.CEL
whole blood of Interferon treated MS patient, sample 41262.0001B, Interferon Analysis, discovery data set


title: MS patient 600327.0001, follow-up year 2 visit

description:
600327.0001C.CEL
whole blood of untreated MS patient, sample 600327.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41815.0001, Baseline visit

description:
41815.0001A.CEL
whole blood of Interferon treated MS patient, sample 41815.0001A, Interferon Analysis, discovery data set


title: MS patient 600340.0001, follow-up year 2 visit

description:
600340.0001C.CEL
whole blood of untreated MS patient, sample 600340.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600337.0001, follow-up year 1 visit

description:
600337.0001B.CEL
whole blood of untreated MS patient, sample 600337.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600326.0001, follow-up year 2 visit

description:
600326.0001C.CEL
whole blood of Interferon treated MS patient, sample 600326.0001C, Interferon Analysis, discovery data set


title: MS patient 600327.0001, Baseline visit

description:
600327.0001A.CEL
whole blood of untreated MS patient, sample 600327.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600340.0001, follow-up year 1 visit

description:
600340.0001B.CEL
whole blood of untreated MS patient, sample 600340.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600028.0001, follow-up year 1 visit

description:
600028.0001B.CEL
whole blood of Interferon treated MS patient, sample 600028.0001B, Interferon Analysis, replication data set


title: MS patient 41262.0001, follow-up year 2 visit

description:
41262.0001C.CEL
whole blood of Interferon treated MS patient, sample 41262.0001C, Interferon Analysis, discovery data set


title: MS patient 41815.0001, follow-up year 1 visit

description:
41815.0001B.CEL
whole blood of Interferon treated MS patient, sample 41815.0001B, Interferon Analysis, discovery data set


title: MS patient 600315.0001, follow-up year 2 visit

description:
600315.0001C.CEL
whole blood of Interferon treated MS patient, sample 600315.0001C, Interferon Analysis, discovery data set


title: MS patient 600327.0001, follow-up year 1 visit

description:
600327.0001B.CEL
whole blood of untreated MS patient, sample 600327.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600340.0001, Baseline visit

description:
600340.0001A.CEL
whole blood of untreated MS patient, sample 600340.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600326.0001, follow-up year 1 visit

description:
600326.0001B.CEL
whole blood of Interferon treated MS patient, sample 600326.0001B, Interferon Analysis, discovery data set


title: MS patient 600337.0001, follow-up year 2 visit

description:
600337.0001C.CEL
whole blood of Interferon treated MS patient, sample 600337.0001C, Interferon Analysis, discovery data set


title: MS patient 600326.0001, Baseline visit

description:
600326.0001A.CEL
whole blood of Interferon treated MS patient, sample 600326.0001A, Interferon Analysis, discovery data set


title: MS patient 40072.0001, follow-up year 1 visit

description:
40072.0001B.CEL
whole blood of untreated MS patient, sample 40072.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41643.0001, Baseline visit

description:
41643.0001A.CEL
whole blood of untreated MS patient, sample 41643.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600320.0001, follow-up year 2 visit

description:
600320.0001C.CEL
whole blood of Interferon treated MS patient, sample 600320.0001C, Interferon Analysis, discovery data set


title: MS patient 600312.0001, Baseline visit

description:
600312.0001A.CEL
whole blood of Interferon treated MS patient, sample 600312.0001A, Interferon Analysis, discovery data set


title: MS patient 40072.0001, Baseline visit

description:
40072.0001A.CEL
whole blood of Interferon treated MS patient, sample 40072.0001A, Interferon Analysis, discovery data set


title: MS patient 600311.0001, follow-up year 1 visit

description:
600311.0001B.CEL
whole blood of untreated MS patient, sample 600311.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600312.0001, follow-up year 1 visit

description:
600312.0001B.CEL
whole blood of Interferon treated MS patient, sample 600312.0001B, Interferon Analysis, discovery data set


title: MS patient 600312.0001, follow-up year 2 visit

description:
600312.0001C.CEL
whole blood of Interferon treated MS patient, sample 600312.0001C, Interferon Analysis, discovery data set


title: MS patient 41716.0001, Baseline visit

description:
41716.0001A.CEL
whole blood of untreated MS patient, sample 41716.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41720.0001, follow-up year 1 visit

description:
41720.0001B.CEL
whole blood of Interferon treated MS patient, sample 41720.0001B, Interferon Analysis, discovery data set


title: MS patient 600298.0001, follow-up year 2 visit

description:
600298.0001C.CEL
whole blood of Interferon treated MS patient, sample 600298.0001C, Interferon Analysis, discovery data set


title: MS patient 600315.0001, follow-up year 1 visit

description:
600315.0001B.CEL
whole blood of Interferon treated MS patient, sample 600315.0001B, Interferon Analysis, discovery data set


title: MS patient 600315.0001, Baseline visit

description:
600315.0001A.CEL
whole blood of Interferon treated MS patient, sample 600315.0001A, Interferon Analysis, discovery data set


title: MS patient 41716.0001, follow-up year 1 visit

description:
41716.0001B.CEL
whole blood of Interferon treated MS patient, sample 41716.0001B, Interferon Analysis, discovery data set


title: MS patient 41716.0001, follow-up year 2 visit

description:
41716.0001C.CEL
whole blood of Interferon treated MS patient, sample 41716.0001C, Interferon Analysis, discovery data set


title: MS patient 600311.0001, follow-up year 2 visit

description:
600311.0001C.CEL
whole blood of untreated MS patient, sample 600311.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41720.0001, follow-up year 2 visit

description:
41720.0001C.CEL
whole blood of Interferon treated MS patient, sample 41720.0001C, Interferon Analysis, discovery data set


title: MS patient 41720.0001, Baseline visit

description:
41720.0001A.CEL
whole blood of Interferon treated MS patient, sample 41720.0001A, Interferon Analysis, discovery data set


title: MS patient 41599.0001, follow-up year 2 visit

description:
41599.0001C.CEL
whole blood of untreated MS patient, sample 41599.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41599.0001, follow-up year 1 visit

description:
41599.0001B.CEL
whole blood of untreated MS patient, sample 41599.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600302.0001, follow-up year 1 visit

description:
600302.0001B.CEL
whole blood of untreated MS patient, sample 600302.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600302.0001, Baseline visit

description:
600302.0001A.CEL
whole blood of untreated MS patient, sample 600302.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600298.0001, Baseline visit

description:
600298.0001A.CEL
whole blood of Interferon treated MS patient, sample 600298.0001A, Interferon Analysis, discovery data set


title: MS patient 41586.0001, follow-up year 1 visit

description:
41586.0001B.CEL
whole blood of untreated MS patient, sample 41586.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41596.0001, follow-up year 2 visit

description:
41596.0001C.CEL
whole blood of Interferon treated MS patient, sample 41596.0001C, Interferon Analysis, discovery data set


title: MS patient 600298.0001, follow-up year 1 visit

description:
600298.0001B.CEL
whole blood of Interferon treated MS patient, sample 600298.0001B, Interferon Analysis, discovery data set


title: MS patient 41596.0001, follow-up year 1 visit

description:
41596.0001B.CEL
whole blood of Interferon treated MS patient, sample 41596.0001B, Interferon Analysis, discovery data set


title: MS patient 600302.0001, follow-up year 2 visit

description:
600302.0001C.CEL
whole blood of untreated MS patient, sample 600302.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41596.0001, Baseline visit

description:
41596.0001A.CEL
whole blood of untreated MS patient, sample 41596.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41599.0001, Baseline visit

description:
41599.0001A.CEL
whole blood of untreated MS patient, sample 41599.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600278.0001, follow-up year 1 visit

description:
600278.0001B.CEL
whole blood of Interferon treated MS patient, sample 600278.0001B, Interferon Analysis, discovery data set


title: MS patient 600278.0001, follow-up year 2 visit

description:
600278.0001C.CEL
whole blood of Interferon treated MS patient, sample 600278.0001C, Interferon Analysis, discovery data set


title: MS patient 600278.0001, Baseline visit

description:
600278.0001A.CEL
whole blood of Interferon treated MS patient, sample 600278.0001A, Interferon Analysis, discovery data set


title: MS patient 41586.0001, Baseline visit

description:
41586.0001A.CEL
whole blood of Interferon treated MS patient, sample 41586.0001A, Interferon Analysis, discovery data set


title: MS patient 41627.0001, follow-up year 1 visit

description:
41627.0001B.CEL
whole blood of untreated MS patient, sample 41627.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41627.0001, follow-up year 2 visit

description:
41627.0001C.CEL
whole blood of untreated MS patient, sample 41627.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41627.0001, Baseline visit

description:
41627.0001A.CEL
whole blood of untreated MS patient, sample 41627.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600269.0001, follow-up year 2 visit

description:
600269.0001C.CEL
whole blood of Interferon treated MS patient, sample 600269.0001C, Interferon Analysis, discovery data set


title: MS patient 600269.0001, follow-up year 1 visit

description:
600269.0001B.CEL
whole blood of Interferon treated MS patient, sample 600269.0001B, Interferon Analysis, discovery data set


title: MS patient 600273.0001, follow-up year 2 visit

description:
600273.0001C.CEL
whole blood of untreated MS patient, sample 600273.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600271.0001, Baseline visit

description:
600271.0001A.CEL
whole blood of untreated MS patient, sample 600271.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600269.0001, Baseline visit

description:
600269.0001A.CEL
whole blood of Interferon treated MS patient, sample 600269.0001A, Interferon Analysis, discovery data set


title: MS patient 600267.0001, follow-up year 1 visit

description:
600267.0001B.CEL
whole blood of Interferon treated MS patient, sample 600267.0001B, Interferon Analysis, discovery data set


title: MS patient 600273.0001, follow-up year 1 visit

description:
600273.0001B.CEL
whole blood of untreated MS patient, sample 600273.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600267.0001, follow-up year 2 visit

description:
600267.0001C.CEL
whole blood of Interferon treated MS patient, sample 600267.0001C, Interferon Analysis, discovery data set


title: MS patient 41155.0001, follow-up year 2 visit

description:
41155.0001C.CEL
whole blood of Interferon treated MS patient, sample 41155.0001C, Interferon Analysis, discovery data set


title: MS patient 600271.0001, follow-up year 1 visit

description:
600271.0001B.CEL
whole blood of untreated MS patient, sample 600271.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600271.0001, follow-up year 2 visit

description:
600271.0001C.CEL
whole blood of untreated MS patient, sample 600271.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41155.0001, Baseline visit

description:
41155.0001A.CEL
whole blood of Interferon treated MS patient, sample 41155.0001A, Interferon Analysis, discovery data set


title: MS patient 600267.0001, Baseline visit

description:
600267.0001A.CEL
whole blood of untreated MS patient, sample 600267.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41155.0001, follow-up year 1 visit

description:
41155.0001B.CEL
whole blood of Interferon treated MS patient, sample 41155.0001B, Interferon Analysis, discovery data set


title: MS patient 41593.0001, Baseline visit

description:
41593.0001A.CEL
whole blood of untreated MS patient, sample 41593.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600273.0001, Baseline visit

description:
600273.0001A.CEL
whole blood of untreated MS patient, sample 600273.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600242.0001, Baseline visit

description:
600242.0001A.CEL
whole blood of untreated MS patient, sample 600242.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600242.0001, follow-up year 1 visit

description:
600242.0001B.CEL
whole blood of untreated MS patient, sample 600242.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41572.0001, Baseline visit

description:
41572.0001A.CEL
whole blood of untreated MS patient, sample 41572.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41593.0001, follow-up year 2 visit

description:
41593.0001C.CEL
whole blood of untreated MS patient, sample 41593.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600236.0001, follow-up year 2 visit

description:
600236.0001C.CEL
whole blood of Interferon treated MS patient, sample 600236.0001C, Interferon Analysis, discovery data set


title: MS patient 600242.0001, follow-up year 2 visit

description:
600242.0001C.CEL
whole blood of untreated MS patient, sample 600242.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600223.0001, follow-up year 1 visit

description:
600223.0001B.CEL
whole blood of Interferon treated MS patient, sample 600223.0001B, Interferon Analysis, discovery data set


title: MS patient 600236.0001, follow-up year 1 visit

description:
600236.0001B.CEL
whole blood of Interferon treated MS patient, sample 600236.0001B, Interferon Analysis, discovery data set


title: MS patient 41564.0001, follow-up year 2 visit

description:
41564.0001C.CEL
whole blood of Interferon treated MS patient, sample 41564.0001C, Interferon Analysis, discovery data set


title: MS patient 600222.0001, follow-up year 2 visit

description:
600222.0001C.CEL
whole blood of untreated MS patient, sample 600222.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41564.0001, follow-up year 1 visit

description:
41564.0001B.CEL
whole blood of Interferon treated MS patient, sample 41564.0001B, Interferon Analysis, discovery data set


title: MS patient 600222.0001, follow-up year 1 visit

description:
600222.0001B.CEL
whole blood of Interferon treated MS patient, sample 600222.0001B, Interferon Analysis, discovery data set


title: MS patient 600218.0001, follow-up year 2 visit

description:
600218.0001C.CEL
whole blood of untreated MS patient, sample 600218.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600223.0001, follow-up year 2 visit

description:
600223.0001C.CEL
whole blood of untreated MS patient, sample 600223.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600218.0001, follow-up year 1 visit

description:
600218.0001B.CEL
whole blood of untreated MS patient, sample 600218.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600222.0001, Baseline visit

description:
600222.0001A.CEL
whole blood of untreated MS patient, sample 600222.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600218.0001, Baseline visit

description:
600218.0001A.CEL
whole blood of untreated MS patient, sample 600218.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600223.0001, Baseline visit

description:
600223.0001A.CEL
whole blood of Interferon treated MS patient, sample 600223.0001A, Interferon Analysis, discovery data set


title: MS patient 600236.0001, Baseline visit

description:
600236.0001A.CEL
whole blood of Interferon treated MS patient, sample 600236.0001A, Interferon Analysis, discovery data set


title: MS patient 41555.0001, follow-up year 1 visit

description:
41555.0001B.CEL
whole blood of Interferon treated MS patient, sample 41555.0001B, Interferon Analysis, discovery data set


title: MS patient 41556.0001, follow-up year 1 visit

description:
41556.0001B.CEL
whole blood of untreated MS patient, sample 41556.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41556.0001, Baseline visit

description:
41556.0001A.CEL
whole blood of untreated MS patient, sample 41556.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41564.0001, Baseline visit

description:
41564.0001A.CEL
whole blood of Interferon treated MS patient, sample 41564.0001A, Interferon Analysis, discovery data set


title: MS patient 600209.0001, follow-up year 1 visit

description:
600209.0001B.CEL
whole blood of untreated MS patient, sample 600209.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41549.0001, follow-up year 1 visit

description:
41549.0001B.CEL
whole blood of Interferon treated MS patient, sample 41549.0001B, Interferon Analysis, discovery data set


title: MS patient 41549.0001, follow-up year 2 visit

description:
41549.0001C.CEL
whole blood of Interferon treated MS patient, sample 41549.0001C, Interferon Analysis, discovery data set


title: MS patient 600209.0001, Baseline visit

description:
600209.0001A.CEL
whole blood of untreated MS patient, sample 600209.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600195.0001, Baseline visit

description:
600195.0001A.CEL
whole blood of Interferon treated MS patient, sample 600195.0001A, Interferon Analysis, discovery data set


title: MS patient 600200.0001, follow-up year 1 visit

description:
600200.0001B.CEL
whole blood of Interferon treated MS patient, sample 600200.0001B, Interferon Analysis, discovery data set


title: MS patient 40173.0001, follow-up year 2 visit

description:
40173.0001C.CEL
whole blood of Interferon treated MS patient, sample 40173.0001C, Interferon Analysis, discovery data set


title: MS patient 600200.0001, Baseline visit

description:
600200.0001A.CEL
whole blood of Interferon treated MS patient, sample 600200.0001A, Interferon Analysis, discovery data set


title: MS patient 600198.0001, Baseline visit

description:
600198.0001A.CEL
whole blood of Interferon treated MS patient, sample 600198.0001A, Interferon Analysis, discovery data set


title: MS patient 600338.0001, follow-up year 1 visit

description:
600338.0001B.CEL
whole blood of Interferon treated MS patient, sample 600338.0001B, Interferon Analysis, discovery data set


title: MS patient 41549.0001, Baseline visit

description:
41549.0001A.CEL
whole blood of untreated MS patient, sample 41549.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600200.0001, follow-up year 2 visit

description:
600200.0001C.CEL
whole blood of Interferon treated MS patient, sample 600200.0001C, Interferon Analysis, discovery data set


title: MS patient 600209.0001, follow-up year 2 visit

description:
600209.0001C.CEL
whole blood of untreated MS patient, sample 600209.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 40173.0001, follow-up year 1 visit

description:
40173.0001B.CEL
whole blood of Interferon treated MS patient, sample 40173.0001B, Interferon Analysis, discovery data set


title: MS patient 600186.0001, follow-up year 1 visit

description:
600186.0001B.CEL
whole blood of Interferon treated MS patient, sample 600186.0001C, Interferon Analysis, discovery data set


title: MS patient 41534.0001, follow-up year 1 visit

description:
41534.0001B.CEL
whole blood of Interferon treated MS patient, sample 41534.0001B, Interferon Analysis, discovery data set


title: MS patient 600180.0001, follow-up year 2 visit

description:
600180.0001C.CEL
whole blood of Interferon treated MS patient, sample 600180.0001C, Interferon Analysis, discovery data set


title: MS patient 41534.0001, Baseline visit

description:
41534.0001A.CEL
whole blood of untreated MS patient, sample 41534.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600180.0001, Baseline visit

description:
600180.0001A.CEL
whole blood of Interferon treated MS patient, sample 600180.0001A, Interferon Analysis, discovery data set


title: MS patient 600186.0001, follow-up year 2 visit

description:
600186.0001C.CEL
whole blood of Interferon treated MS patient, sample 600186.0001B, Interferon Analysis, discovery data set


title: MS patient 600186.0001, Baseline visit

description:
600186.0001A.CEL
whole blood of Interferon treated MS patient, sample 600186.0001A, Interferon Analysis, discovery data set


title: MS patient 600185.0001, Baseline visit

description:
600185.0001A.CEL
whole blood of Interferon treated MS patient, sample 600185.0001A, Interferon Analysis, discovery data set


title: MS patient 600180.0001, follow-up year 1 visit

description:
600180.0001B.CEL
whole blood of Interferon treated MS patient, sample 600180.0001B, Interferon Analysis, discovery data set


title: MS patient 41531.0001, follow-up year 2 visit

description:
41531.0001C.CEL
whole blood of untreated MS patient, sample 41531.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41530.0001, follow-up year 2 visit

description:
41530.0001C.CEL
whole blood of Interferon treated MS patient, sample 41530.0001C, Interferon Analysis, discovery data set


title: MS patient 41531.0001, Baseline visit

description:
41531.0001A.CEL
whole blood of untreated MS patient, sample 41531.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600166.0001, follow-up year 1 visit

description:
600166.0001B.CEL
whole blood of untreated MS patient, sample 600166.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600167.0001, Baseline visit

description:
600167.0001A.CEL
whole blood of Interferon treated MS patient, sample 600167.0001A, Interferon Analysis, discovery data set


title: MS patient 41530.0001, follow-up year 1 visit

description:
41530.0001B.CEL
whole blood of Interferon treated MS patient, sample 41530.0001B, Interferon Analysis, discovery data set


title: MS patient 600161.0001, follow-up year 1 visit

description:
600161.0001B.CEL
whole blood of untreated MS patient, sample 600161.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41531.0001, follow-up year 1 visit

description:
41531.0001B.CEL
whole blood of untreated MS patient, sample 41531.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600166.0001, follow-up year 2 visit

description:
600166.0001C.CEL
whole blood of untreated MS patient, sample 600166.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600162.0001, Baseline visit

description:
600162.0001A.CEL
whole blood of untreated MS patient, sample 600162.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600166.0001, Baseline visit

description:
600166.0001A.CEL
whole blood of untreated MS patient, sample 600166.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600161.0001, follow-up year 2 visit

description:
600161.0001C.CEL
whole blood of untreated MS patient, sample 600161.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41534.0001, follow-up year 2 visit

description:
41534.0001C.CEL
whole blood of Interferon treated MS patient, sample 41534.0001C, Interferon Analysis, discovery data set


title: MS patient 600167.0001, follow-up year 2 visit

description:
600167.0001C.CEL
whole blood of Interferon treated MS patient, sample 600167.0001C, Interferon Analysis, discovery data set


title: MS patient 600167.0001, follow-up year 1 visit

description:
600167.0001B.CEL
whole blood of Interferon treated MS patient, sample 600167.0001B, Interferon Analysis, discovery data set


title: MS patient 41530.0001, Baseline visit

description:
41530.0001A.CEL
whole blood of untreated MS patient, sample 41530.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600162.0001, follow-up year 2 visit

description:
600162.0001C.CEL
whole blood of untreated MS patient, sample 600162.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600162.0001, follow-up year 1 visit

description:
600162.0001B.CEL
whole blood of untreated MS patient, sample 600162.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600158.0001, Baseline visit

description:
600158.0001A.CEL
whole blood of Interferon treated MS patient, sample 600158.0001A, Interferon Analysis, discovery data set


title: MS patient 600158.0001, follow-up year 1 visit

description:
600158.0001B.CEL
whole blood of Interferon treated MS patient, sample 600158.0001B, Interferon Analysis, discovery data set


title: MS patient 41293.0001, follow-up year 2 visit

description:
41293.0001C.CEL
whole blood of untreated MS patient, sample 41293.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600161.0001, Baseline visit

description:
600161.0001A.CEL
whole blood of untreated MS patient, sample 600161.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600153.0001, follow-up year 1 visit

description:
600153.0001B.CEL
whole blood of untreated MS patient, sample 600153.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41526.0001, follow-up year 2 visit

description:
41526.0001C.CEL
whole blood of Interferon treated MS patient, sample 41526.0001C, Interferon Analysis, discovery data set


title: MS patient 600153.0001, Baseline visit

description:
600153.0001A.CEL
whole blood of untreated MS patient, sample 600153.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600158.0001, follow-up year 2 visit

description:
600158.0001C.CEL
whole blood of Interferon treated MS patient, sample 600158.0001C, Interferon Analysis, discovery data set


title: MS patient 41293.0001, follow-up year 1 visit

description:
41293.0001B.CEL
whole blood of untreated MS patient, sample 41293.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600153.0001, follow-up year 2 visit

description:
600153.0001C.CEL
whole blood of untreated MS patient, sample 600153.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41293.0001, Baseline visit

description:
41293.0001A.CEL
whole blood of untreated MS patient, sample 41293.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41526.0001, Baseline visit

description:
41526.0001A.CEL
whole blood of Interferon treated MS patient, sample 41526.0001A, Interferon Analysis, discovery data set


title: MS patient 600147.0001, Baseline visit

description:
600147.0001A.CEL
whole blood of Interferon treated MS patient, sample 600147.0001A, Interferon Analysis, discovery data set


title: MS patient 41527.0001, Baseline visit

description:
41527.0001A.CEL
whole blood of Interferon treated MS patient, sample 41527.0001A, Interferon Analysis, discovery data set


title: MS patient 41526.0001, follow-up year 1 visit

description:
41526.0001B.CEL
whole blood of Interferon treated MS patient, sample 41526.0001B, Interferon Analysis, discovery data set


title: MS patient 41527.0001, follow-up year 1 visit

description:
41527.0001B.CEL
whole blood of Interferon treated MS patient, sample 41527.0001B, Interferon Analysis, discovery data set


title: MS patient 41527.0001, follow-up year 2 visit

description:
41527.0001C.CEL
whole blood of untreated MS patient, sample 41527.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600139.0001, Baseline visit

description:
600139.0001A.CEL
whole blood of untreated MS patient, sample 600139.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600147.0001, follow-up year 1 visit

description:
600147.0001B.CEL
whole blood of Interferon treated MS patient, sample 600147.0001B, Interferon Analysis, discovery data set


title: MS patient 600134.0001, follow-up year 2 visit

description:
600134.0001C.CEL
whole blood of untreated MS patient, sample 600134.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600139.0001, follow-up year 1 visit

description:
600139.0001B.CEL
whole blood of untreated MS patient, sample 600139.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600134.0001, follow-up year 1 visit

description:
600134.0001B.CEL
whole blood of untreated MS patient, sample 600134.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600143.0001, Baseline visit

description:
600143.0001A.CEL
whole blood of Interferon treated MS patient, sample 600143.0001A, Interferon Analysis, discovery data set


title: MS patient 41568.0001, follow-up year 2 visit

description:
41568.0001C.CEL
whole blood of Interferon treated MS patient, sample 41568.0001C, Interferon Analysis, discovery data set


title: MS patient 600141.0001, follow-up year 1 visit

description:
600141.0001B.CEL
whole blood of untreated MS patient, sample 600141.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600139.0001, follow-up year 2 visit

description:
600139.0001C.CEL
whole blood of untreated MS patient, sample 600139.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600134.0001, Baseline visit

description:
600134.0001A.CEL
whole blood of untreated MS patient, sample 600134.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600130.0001, follow-up year 1 visit

description:
600130.0001B.CEL
whole blood of untreated MS patient, sample 600130.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600130.0001, follow-up year 2 visit

description:
600130.0001C.CEL
whole blood of Interferon treated MS patient, sample 600130.0001C, Interferon Analysis, discovery data set


title: MS patient 600147.0001, follow-up year 2 visit

description:
600147.0001C.CEL
whole blood of Interferon treated MS patient, sample 600147.0001C, Interferon Analysis, discovery data set


title: MS patient 600127.0001, follow-up year 2 visit

description:
600127.0001C.CEL
whole blood of Interferon treated MS patient, sample 600127.0001C, Interferon Analysis, discovery data set


title: MS patient 600185.0001, follow-up year 1 visit

description:
600185.0001B.CEL
whole blood of Interferon treated MS patient, sample 600185.0001B, Interferon Analysis, discovery data set


title: MS patient 40173.0001, Baseline visit

description:
40173.0001A.CEL
whole blood of Interferon treated MS patient, sample 40173.0001A, Interferon Analysis, discovery data set


title: MS patient 600127.0001, Baseline visit

description:
600127.0001A.CEL
whole blood of Interferon treated MS patient, sample 600127.0001A, Interferon Analysis, discovery data set


title: MS patient 600127.0001, follow-up year 1 visit

description:
600127.0001B.CEL
whole blood of Interferon treated MS patient, sample 600127.0001B, Interferon Analysis, discovery data set


title: MS patient 600130.0001, Baseline visit

description:
600130.0001A.CEL
whole blood of Interferon treated MS patient, sample 600130.0001A, Interferon Analysis, discovery data set


title: MS patient 600126.0001, follow-up year 2 visit

description:
600126.0001C.CEL
whole blood of Interferon treated MS patient, sample 600126.0001C, Interferon Analysis, discovery data set


title: MS patient 600125.0001, follow-up year 1 visit

description:
600125.0001B.CEL
whole blood of Interferon treated MS patient, sample 600125.0001B, Interferon Analysis, discovery data set


title: MS patient 600126.0001, follow-up year 1 visit

description:
600126.0001B.CEL
whole blood of Interferon treated MS patient, sample 600126.0001B, Interferon Analysis, discovery data set


title: MS patient 600125.0001, Baseline visit

description:
600125.0001A.CEL
whole blood of Interferon treated MS patient, sample 600125.0001A, Interferon Analysis, discovery data set


title: MS patient 600125.0001, follow-up year 2 visit

description:
600125.0001C.CEL
whole blood of Interferon treated MS patient, sample 600125.0001C, Interferon Analysis, discovery data set


title: MS patient 600126.0001, Baseline visit

description:
600126.0001A.CEL
whole blood of Interferon treated MS patient, sample 600126.0001A, Interferon Analysis, discovery data set


title: MS patient 600112.0001, follow-up year 2 visit

description:
600112.0001C.CEL
whole blood of Interferon treated MS patient, sample 600112.0001C, Interferon Analysis, discovery data set


title: MS patient 41510.0001, follow-up year 2 visit

description:
41510.0001C.CEL
whole blood of Interferon treated MS patient, sample 41510.0001C, Interferon Analysis, discovery data set


title: MS patient 600112.0001, Baseline visit

description:
600112.0001A.CEL
whole blood of Interferon treated MS patient, sample 600112.0001A, Interferon Analysis, discovery data set


title: MS patient 600112.0001, follow-up year 1 visit

description:
600112.0001B.CEL
whole blood of Interferon treated MS patient, sample 600112.0001B, Interferon Analysis, discovery data set


title: MS patient 41510.0001, follow-up year 1 visit

description:
41510.0001B.CEL
whole blood of Interferon treated MS patient, sample 41510.0001B, Interferon Analysis, discovery data set


title: MS patient 41510.0001, Baseline visit

description:
41510.0001A.CEL
whole blood of untreated MS patient, sample 41510.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600104.0001, follow-up year 2 visit

description:
600104.0001C.CEL
whole blood of Interferon treated MS patient, sample 600104.0001C, Interferon Analysis, discovery data set


title: MS patient 600095.0001, follow-up year 1 visit

description:
600095.0001B.CEL
whole blood of Interferon treated MS patient, sample 600095.0001B, Interferon Analysis, discovery data set


title: MS patient 600096.0001, follow-up year 1 visit

description:
600096.0001B.CEL
whole blood of untreated MS patient, sample 600096.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600095.0001, Baseline visit

description:
600095.0001A.CEL
whole blood of Interferon treated MS patient, sample 600095.0001A, Interferon Analysis, discovery data set


title: MS patient 2964.0001, follow-up year 1 visit

description:
2964.0001B.CEL
whole blood of Interferon treated MS patient, sample 2964.0001B, Interferon Analysis, discovery data set


title: MS patient 600096.0001, Baseline visit

description:
600096.0001A.CEL
whole blood of untreated MS patient, sample 600096.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 2973.0001, follow-up year 1 visit

description:
2973.0001B.CEL
whole blood of Interferon treated MS patient, sample 2973.0001B, Interferon Analysis, discovery data set


title: MS patient 2964.0001, Baseline visit

description:
2964.0001A.CEL
whole blood of Interferon treated MS patient, sample 2964.0001A, Interferon Analysis, discovery data set


title: MS patient 600104.0001, follow-up year 1 visit

description:
600104.0001B.CEL
whole blood of Interferon treated MS patient, sample 600104.0001B, Interferon Analysis, discovery data set


title: MS patient 600096.0001, follow-up year 2 visit

description:
600096.0001C.CEL
whole blood of untreated MS patient, sample 600096.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 2964.0001, follow-up year 2 visit

description:
2964.0001C.CEL
whole blood of Interferon treated MS patient, sample 2964.0001C, Interferon Analysis, discovery data set


title: MS patient 41509.0001, Baseline visit

description:
41509.0001A.CEL
whole blood of untreated MS patient, sample 41509.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41509.0001, follow-up year 2 visit

description:
41509.0001C.CEL
whole blood of untreated MS patient, sample 41509.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600104.0001, Baseline visit

description:
600104.0001A.CEL
whole blood of untreated MS patient, sample 600104.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41509.0001, follow-up year 1 visit

description:
41509.0001B.CEL
whole blood of untreated MS patient, sample 41509.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600087.0001, Baseline visit

description:
600087.0001A.CEL
whole blood of Interferon treated MS patient, sample 600087.0001A, Interferon Analysis, discovery data set


title: MS patient 41245.0001, follow-up year 2 visit

description:
41245.0001C.CEL
whole blood of Interferon treated MS patient, sample 41245.0001C, Interferon Analysis, discovery data set


title: MS patient 41245.0001, follow-up year 1 visit

description:
41245.0001B.CEL
whole blood of Interferon treated MS patient, sample 41245.0001B, Interferon Analysis, discovery data set


title: MS patient 600071.0001, follow-up year 2 visit

description:
600071.0001C.CEL
whole blood of Interferon treated MS patient, sample 600071.0001C, Interferon Analysis, discovery data set


title: MS patient 600087.0001, follow-up year 2 visit

description:
600087.0001C.CEL
whole blood of Interferon treated MS patient, sample 600087.0001C, Interferon Analysis, discovery data set


title: MS patient 600087.0001, follow-up year 1 visit

description:
600087.0001B.CEL
whole blood of Interferon treated MS patient, sample 600087.0001B, Interferon Analysis, discovery data set


title: MS patient 600071.0001, follow-up year 1 visit

description:
600071.0001B.CEL
whole blood of Interferon treated MS patient, sample 600071.0001B, Interferon Analysis, discovery data set


title: MS patient 41245.0001, Baseline visit

description:
41245.0001A.CEL
whole blood of Interferon treated MS patient, sample 41245.0001A, Interferon Analysis, discovery data set


title: MS patient 600070.0001, follow-up year 2 visit

description:
600070.0001C.CEL
whole blood of Interferon treated MS patient, sample 600070.0001C, Interferon Analysis, discovery data set


title: MS patient 600071.0001, Baseline visit

description:
600071.0001A.CEL
whole blood of Interferon treated MS patient, sample 600071.0001A, Interferon Analysis, discovery data set


title: MS patient 2973.0001, Baseline visit

description:
2973.0001A.CEL
whole blood of Interferon treated MS patient, sample 2973.0001A, Interferon Analysis, discovery data set


title: MS patient 600070.0001, follow-up year 1 visit

description:
600070.0001B.CEL
whole blood of Interferon treated MS patient, sample 600070.0001B, Interferon Analysis, discovery data set


title: MS patient 41497.0001, follow-up year 2 visit

description:
41497.0001C.CEL
whole blood of untreated MS patient, sample 41497.0001C, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41496.0001, follow-up year 2 visit

description:
41496.0001C.CEL
whole blood of Interferon treated MS patient, sample 41496.0001C, Interferon Analysis, discovery data set


title: MS patient 41492.0001, follow-up year 1 visit

description:
41492.0001B.CEL
whole blood of Interferon treated MS patient, sample 41492.0001B, Interferon Analysis, discovery data set


title: MS patient 41497.0001, Baseline visit

description:
41497.0001A.CEL
whole blood of untreated MS patient, sample 41497.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600055.0001, follow-up year 1 visit

description:
600055.0001B.CEL
whole blood of Interferon treated MS patient, sample 600055.0001B, Interferon Analysis, discovery data set


title: MS patient 41496.0001, follow-up year 1 visit

description:
41496.0001B.CEL
whole blood of Interferon treated MS patient, sample 41496.0001B, Interferon Analysis, discovery data set


title: MS patient 41497.0001, follow-up year 1 visit

description:
41497.0001B.CEL
whole blood of untreated MS patient, sample 41497.0001B, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 600055.0001, follow-up year 2 visit

description:
600055.0001C.CEL
whole blood of Interferon treated MS patient, sample 600055.0001C, Interferon Analysis, discovery data set


title: MS patient 41485.0001, follow-up year 2 visit

description:
41485.0001C.CEL
whole blood of Interferon treated MS patient, sample 41485.0001C, Interferon Analysis, discovery data set


title: MS patient 600029.0001, follow-up year 1 visit

description:
600029.0001B.CEL
whole blood of Interferon treated MS patient, sample 600029.0001B, Interferon Analysis, discovery data set


title: MS patient 41466.0001, follow-up year 2 visit

description:
41466.0001C.CEL
whole blood of Interferon treated MS patient, sample 41466.0001C, Interferon Analysis, discovery data set


title: MS patient 41492.0001, Baseline visit

description:
41492.0001A.CEL
whole blood of Interferon treated MS patient, sample 41492.0001A, Interferon Analysis, discovery data set


title: MS patient 41490.0001, follow-up year 2 visit

description:
41490.0001C.CEL
whole blood of Interferon treated MS patient, sample 41490.0001C, Interferon Analysis, discovery data set


title: MS patient 41490.0001, follow-up year 1 visit

description:
41490.0001B.CEL
whole blood of Interferon treated MS patient, sample 41490.0001B, Interferon Analysis, discovery data set


title: MS patient 41485.0001, Baseline visit

description:
41485.0001A.CEL
whole blood of untreated MS patient, sample 41485.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41490.0001, Baseline visit

description:
41490.0001A.CEL
whole blood of Interferon treated MS patient, sample 41490.0001A, Interferon Analysis, discovery data set


title: MS patient 600055.0001, Baseline visit

description:
600055.0001A.CEL
whole blood of Interferon treated MS patient, sample 600055.0001A, Interferon Analysis, discovery data set


title: MS patient 600029.0001, Baseline visit

description:
600029.0001A.CEL
whole blood of untreated MS patient, sample 600029.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41466.0001, Baseline visit

description:
41466.0001A.CEL
whole blood of Interferon treated MS patient, sample 41466.0001A, Interferon Analysis, discovery data set


title: MS patient 41462.0001, follow-up year 1 visit

description:
41462.0001C.CEL
whole blood of Interferon treated MS patient, sample 41462.0001C, Interferon Analysis, discovery data set


title: MS patient 41462.0001, follow-up year 2 visit

description:
41462.0001B.CEL
whole blood of Interferon treated MS patient, sample 41462.0001B, Interferon Analysis, discovery data set


title: MS patient 41492.0001, follow-up year 2 visit

description:
41492.0001C.CEL
whole blood of Interferon treated MS patient, sample 41492.0001C, Interferon Analysis, discovery data set


title: MS patient 41496.0001, Baseline visit

description:
41496.0001A.CEL
whole blood of Interferon treated MS patient, sample 41496.0001A, Interferon Analysis, discovery data set


title: MS patient 41462.0001, Baseline visit

description:
41462.0001A.CEL
whole blood of untreated MS patient, sample 41462.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 40199.0001, Baseline visit

description:
40199.0001A.CEL
whole blood of Interferon treated MS patient, sample 40199.0001A, Interferon Analysis, discovery data set


title: MS patient 41524.0001, Baseline visit

description:
41524.0001A.CEL
whole blood of Interferon treated MS patient, sample 41524.0001A, Interferon Analysis, discovery data set


title: MS patient 41461.0001, Baseline visit

description:
41461.0001A.CEL
whole blood of untreated MS patient, sample 41461.0001A, Interferon Analysis, discovery data set
re-analyzed


title: MS patient 41485.0001, follow-up year 1 visit

description:
41485.0001B.CEL
whole blood of Interferon treated MS patient, sample 41485.0001B, Interferon Analysis, discovery data set


title: MS patient 41466.0001, follow-up year 1 visit

description:
41466.0001B.CEL
whole blood of Interferon treated MS patient, sample 41466.0001B, Interferon Analysis, discovery data set


title: MS patient 40199.0001, follow-up year 2 visit

description:
40199.0001C.CEL
whole blood of Interferon treated MS patient, sample 40199.0001C, Interferon Analysis, discovery data set


title: MS patient 40199.0001, follow-up year 1 visit

description:
40199.0001B.CEL
whole blood of Interferon treated MS patient, sample 40199.0001B, Interferon Analysis, discovery data set


title: MS patient 41465.0001, Baseline visit

description:
41465.0001A.CEL
whole blood of Interferon treated MS patient, sample 41465.0001A, Interferon Analysis, discovery data set


title: MS patient 600009.0001, Baseline visit

description:
600009.0001A.CEL
whole blood of untreated MS patient, sample 600009.0001A, Interferon Analysis, discovery data set
re-analyzed


title: Old HSC Rep3

status: Public on Feb 14 2013

city: Boston

first: Isabel

last: Beerman

state: MA

address: 200 Longwood Ave, WAB 156

institute: Boston Childrens Hospital

hyb_protocol: Following fragmentation, cRNA were hybridized for 16 hr at 45C on GeneChip Mouse 430 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400

scan_protocol: GeneChips were scanned using the GeneChip 3000 7G with GCOS version 1.4.0.036

data_processing: The data were normalized using GC-RMA in R using the the gcrma package from Bioconductor.

organism: Mus musculus

source_name: Old HSC

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol

extract_protocol: Total RNA extraction using standard methods.

tag: strain

tag: age

value: 25 months

value: bone marrow

tag: cell type

value: hematopoietic stem cells


title: MS patient 41465.0001, follow-up year 1 visit

description:
41465.0001B.CEL
whole blood of Interferon treated MS patient, sample 41465.0001B, Interferon Analysis, discovery data set


title: Fetal Liver HSC Rep3

source_name: Fetal Liver HSC

value: fetal liver


title: MS patient 600009.0001, follow-up year 1 visit

description:
600009.0001B.CEL
whole blood of untreated MS patient, sample 600009.0001B, Interferon Analysis, discovery data set
re-analyzed


title: Old HSC Rep2

value: male


title: SPORE MM_989_3

status: Public on Sep 10 2012

first: Nikhil

middle: C

last: Munshi

address: 450 Brookline Avenue

department: Hematologic Oncology

institute: Dana-Farber Cancer Institute

hyb_protocol: Samples were analyzed using the Affymetrix GeneChip Human Exon 1.0 ST Array (Affymetirx, Santa Clara, CA) according to the manufacturer's instructions.

scan_protocol: Array scanning was performed according to the manufacturer's instructions (Affymetrix).

data_processing:
The aroma.affymetrix package was utilized for pre-processing and RMA normalization of the data.
HuEx-1_0-st-v2,core,A20071112,EP.cdf

source_name: CD138 purified myeloma plasma cells

label_protocol: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix), and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).

growth_protocol: not applicable

extract_protocol: Total RNA extracted

treatment_protocol:
All patient samples were from newly diagnosed patients with multiple myeloma. Samples were collected before initiation of primary treatment and CD138 purified plasma cells were isolated. All patients received triple drug regime - Vincristine, Adriamycin, and Dexamethasone (VAD) - as induction therapy followed by Autologous Stem Cell Transplant (ASCT) as a maintenenace therapy. 'Treatment response' was measured post-ASCT.
Treatment responses: Complete Response (CR); Very Good Partial Response (VGPR); Partial Response (PR); No Response, Stable disease (NR); No Response, Progressive disease (Prog).

tag: diagnosis

value: newly diagnosed multiple myeloma

value: CR


title: SPORE MM_3833_3


title: SPORE MM_3775_3


title: SPORE MM_501_3

value: PR


title: Fetal Liver HSC Rep1


title: Old HSC Rep1


title: VCaP_siPIAS1_testo_2

status: Public on Jan 01 2013

city: Kuopio

first: Sari

last: Toropainen

address: Yliopistonranta 1 E

department: School of Medicine

country: Finland

institute: University of Eastern Finland

description: Replicate 2

hyb_protocol: 750 ng of each cRNA sample hybridised with Illuminan Sentrix  HumanHT-12 v4 Expression Bead Chip mikroarray at 58 °C over night using Illumina Whole-Genome Gene Expression Direct  Hybridization Assay Guide protocol (part #11322355,  rev.A). Detection was carried out with 1 μg/ml Cyanine3-streptavidin.

scan_protocol: Microarrays scanned by Illumina Bead Array Reader (Factor=1.5, PMT=520, Filter=100%) and non-normalized numeric results were generated by GenomeStudio v. 2010.2; Gene Expression Module v.1.7.0 program

data_processing: The data were normalized using VST transformation and RSN normalization used as standard approach for Illumina arrays with the R/lumi package

source_name: VCaP

label_protocol: Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays

growth_protocol: The cells were grown in DMEM containing 10% (v/v) US defined FBS, 25 U/ml penicillin and 25 µg/ml streptomycin in a 5% CO2 atmosphere at 37 °C.

extract_protocol: RNA was extracted with Trizol reagent. Quality control was performed with Agilent Bioanalyser.

treatment_protocol: 100h prior to mRNA extraction cells were grown in DMEM supplemented with 2.5% charcoal-stripped FBS. After 4h the cells were transfected with Dharmacon ON-TARGETplus siRNA pools (siSCR or siPIAS1) using siQUEST (Mirus) transfectionreagent. 16h before RNA extraction the cells were treated with 100 nM testosterone as indicated.

tag: cell line

value: Vertebral Cancer of Prostate (VCaP)

tag: origin

value: bone metastasis of prostate cancer

tag: sirna

tag: testosterone treatment

value: 100 nM testosterone

tag: time


title: SPORE MM_838_3


title: SPORE MM_3788_3


title: Fetal Liver HSC Rep2


title: SPORE MM_997_3


title: SPORE MM_3767_3


title: SPORE MM_3750_3

value: VGPR


title: VCaP_siPIAS1_testo_3

description: Replicate 3


title: VCaP_siPIAS1_1

description: Replicate 1


title: VCaP_siSCR_testo_2

description: Replicate 2

value: siSCR (control)


title: VCaP_siPIAS1_3

description: Replicate 3


title: SPORE MM_588_3


title: VCaP_siSCR_1

description: Replicate 1


title: VCaP_siSCR_3

description: Replicate 3


title: SPORE MM_3745_3


title: VCaP_siPIAS1_testo_1

description: Replicate 1


title: VCaP_siSCR_2

description: Replicate 2


title: SPORE MM_3628_3

value: Prog


title: VCaP_siSCR_testo_3

description: Replicate 3


title: SPORE MM_3723_3


title: SPORE MM_3567_3


title: VCaP_siPIAS1_2

description: Replicate 2


title: VCaP_siSCR_testo_1

description: Replicate 1


title: SPORE MM_3477_3


title: SPORE MM_3556_3


title: SPORE MM_3576_3


title: SPORE MM_3711_3


title: SPORE MM_3579_3


title: SPORE MM_3480_3


title: SPORE MM_3486_3


title: SPORE MM_3597_3


title: SPORE MM_3614_3


title: SPORE MM_3589_3


title: SPORE MM_3539_3


title: SPORE MM_3535_3


title: SPORE MM_3558_3


title: SPORE MM_3612_3


title: SPORE MM_3476_3


title: SPORE MM_3458_3


title: SPORE MM_3415_3


title: SPORE MM_3420_3


title: SPORE MM_3467_3


title: SPORE MM_3572_3


title: SPORE MM_3400_3


title: SPORE MM_3328_3


title: SPORE MM_3361_3


title: SPORE MM_3294_3


title: SPORE MM_3375_3


title: SPORE MM_3166_3


title: SPORE MM_3286_3


title: SPORE MM_3352_3


title: SPORE MM_3164_3


title: SPORE MM_3255_3


title: SPORE MM_3339b_3


title: SPORE MM_3242_3

value: NR


title: SPORE MM_3085_3


title: SPORE MM_3121_3


title: SPORE MM_3243_3


title: SPORE MM_3089_3


title: SPORE MM_3306_3


title: SPORE MM_3186_3


title: SPORE MM_3298_3


title: SPORE MM_3322_3


title: SPORE MM_3110_3


title: SPORE MM_3065_3


title: SPORE MM_3224_3


title: SPORE MM_3071_3


title: SPORE MM_3038_3


title: SPORE MM_2989_3


title: SPORE MM_3251_3


title: SPORE MM_2980_3


title: SPORE MM_2977_3


title: SPORE MM_2992_3


title: SPORE MM_3044_3


title: SPORE MM_2912_3


title: SPORE MM_2893_3


title: SPORE MM_3062_3


title: SPORE MM_2964_3


title: SPORE MM_2900_3


title: SPORE MM_2806_3


title: SPORE MM_2860_3


title: SPORE MM_2923_3


title: SPORE MM_2833_3


title: SPORE MM_2855_3


title: SPORE MM_2773_3


title: SPORE MM_2958_3


title: SPORE MM_2874_3


title: SPORE MM_2968_3


title: SPORE MM_2740_3


title: SPORE MM_2669_3


title: SPORE MM_2739_3


title: SPORE MM_2679_3


title: SPORE MM_2880_3


title: SPORE MM_2733_3


title: SPORE MM_2668_3


title: SPORE MM_2789_3


title: SPORE MM_2825_3


title: SPORE MM_3018_3


title: SPORE MM_2793_3


title: SPORE MM_2583_3


title: SPORE MM_2570_3


title: SPORE MM_2660_3


title: SPORE MM_2667_3


title: SPORE MM_2567_3


title: SPORE MM_2571_3


title: SPORE MM_2554_3


title: SPORE MM_2369_3


title: SPORE MM_2516_3


title: SPORE MM_2508_3


title: SPORE MM_2482_3


title: SPORE MM_2424_3


title: SPORE MM_2530_3


title: SPORE MM_2548_3


title: SPORE MM_2490_3


title: SPORE MM_2438_3


title: SPORE MM_2301_3


title: SPORE MM_2384_3


title: SPORE MM_2351_3


title: SPORE MM_2021_3


title: SPORE MM_2011_3


title: SPORE MM_2229_3


title: SPORE MM_1969_3


title: SPORE MM_2526_3


title: SPORE MM_1972_3


title: SPORE MM_1961_3


title: SPORE MM_2331_3


title: SPORE MM_2552_3


title: SPORE MM_2475_3


title: SPORE MM_2236_3


title: SPORE MM_1917_3


title: SPORE MM_1930_3


title: SPORE MM_1959_3


title: SPORE MM_1926_3


title: SPORE MM_1960_3


title: SPORE MM_1918_3


title: SPORE MM_1661_3


title: SPORE MM_1630_3


title: SPORE MM_1641_3


title: SPORE MM_1890_3


title: SPORE MM_1898_3


title: SPORE MM_1432_3


title: SPORE MM_1469_3


title: SPORE MM_1631_3


title: SPORE MM_1765_3


title: SPORE MM_1678_3


title: SPORE MM_1775_3


title: SPORE MM_1479_3


title: SPORE MM_1488_3


title: SPORE MM_1717_3


title: SPORE MM_1666_3


title: SPORE MM_1616_3


title: SPORE MM_1509_3


title: SPORE MM_1384_3


title: SPORE MM_1679_3


title: SPORE MM_1612_3


title: SPORE MM_1306_3


title: SPORE MM_1269_3


title: SPORE MM_1244_3


title: SPORE MM_1729_3


title: SPORE MM_1225_3


title: SPORE MM_1086_3


title: SPORE MM_1066_3


title: SPORE MM_1108_3


title: SPORE MM_1032_3


title: SPORE MM_1121_3


title: SPORE MM_1022_3


title: SPORE MM_1012_3


title: SPORE MM_0846_3


title: SPORE MM_0891_3


title: SPORE MM_0825_3


title: SPORE MM_0887_3


title: NM2009042817

source_name: CD138 purified plasma cells

value: Healthy Donor


title: SPORE MM_0865_3


title: SPORE MM_0741_3


title: SPORE MM_0943_3


title: NM2009042816


title: SPORE MM_0998_3


title: NM2009030507


title: SPORE MM_0757_3


title: SPORE MM_0618_3


title: NM2009042818


title: NM2009030505


title: NM2009032406


title: SPORE MM_0834_3


title: SPORE MM_1014_3


title: DN2_rep2 (38_156_DN2)

status: Public on Jul 18 2012

city: Stanford

first: Jun

last: Seita

address: Lokey Stem Cell Building #G3101, 265 Campus Drive

department: Institute for Stem Cell Biology and Regenerative Medicine

institute: Stanford University

description:
p38_s156.cel
Sample name: 38_156_DN2
Re-analysis of GSM507385

hyb_protocol: Following fragmentation, cRNA were hybridized for 16 hr at 45C on GeneChip Mouse 430 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the GeneChip 3000 7G with GCOS version 1.4.0.036.

data_processing: The data were normalized using GC-RMA method on Gene Expression Commons system (http://gexc.stanford.edu/)

source_name: Thymocyte

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol.

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

tag: hematopoiesis population

value: 2 months


title: DN2_rep3 (38_157_DN2)

description:
p38_s157.cel
Sample name: 38_157_DN2
Re-analysis of GSM507386


title: DN3a_rep1 (39_158_DN3a)

description:
p39_s158.cel
Sample name: 39_158_DN3a
Re-analysis of GSM507387


title: DN3a_rep2 (39_159_DN3a)

description:
p39_s159.CEL
Sample name: 39_159_DN3a
Re-analysis of GSM507388


title: DN1_rep1 (37_152_DN1)

description:
p37_s152.cel
Sample name: 37_152_DN1
Re-analysis of GSM507381


title: DN1_rep3 (37_154_DN1)

description:
p37_s154.cel
Sample name: 37_154_DN1
Re-analysis of GSM507383


title: DN2_rep1 (38_155_DN2)

description:
p38_s155.cel
Sample name: 38_155_DN2
Re-analysis of GSM507384


title: DN3a_rep3 (39_160_DN3a)

description:
p39_s160.CEL
Sample name: 39_160_DN3a
Re-analysis of GSM507389


title: DN1_rep2 (37_153_DN1)

description:
p37_s153.cel
Sample name: 37_153_DN1
Re-analysis of GSM507382


title: CLP_rep2 (23_123_CLP)

description:
p23_s123.cel
Sample name: 23_123_CLP
Re-analysis of GSM507379

source_name: Bone marrow

value: CLP


title: CD8+ CD69+_rep1

description:
p46_s179.cel
Sample name: 46_179_CD8+ CD69+

source_name: Thymus


title: CD8+ CD69+_rep3

description:
p46_s181.cel
Sample name: 46_181_CD8+ CD69+


title: DP CD69-_rep3

description:
p42_s169.cel
Sample name: 42_169_DP CD69-

value: DP CD69-


title: CD8+ CD69+_rep2

description:
p46_s180.cel
Sample name: 46_180_CD8+ CD69+


title: CD4+ CD69+_rep2

description:
p44_s174.cel
Sample name: 44_174_CD4+ CD69+


title: CLP_rep3 (23_124_CLP)

description:
p23_s124.cel
Sample name: 23_124_CLP
Re-analysis of GSM507380


title: CD8+ CD69-_rep2

description:
p47_s183.cel
Sample name: 47_183_CD8+ CD69-


title: CD4+ CD69+_rep3

description:
p44_s175.cel
Sample name: 44_175_CD4+ CD69+


title: CD4+ CD69-_rep1

description:
p45_s176.cel
Sample name: 45_176_CD4+ CD69-


title: CD4+ CD69+_rep1

description:
p44_s173.cel
Sample name: 44_173_CD4+ CD69+


title: DN3b_rep3

description:
p40_s163.cel
Sample name: 40_163_DN3b


title: DP CD69+_rep1

description:
p43_s170.cel
Sample name: 43_170_DP CD69+

value: DP CD69+


title: CD4+ CD69-_rep3

description:
p45_s178.cel
Sample name: 45_178_CD4+ CD69-


title: DP CD69+_rep2

description:
p43_s171.cel
Sample name: 43_171_DP CD69+


title: DN3b_rep2

description:
p40_s162.cel
Sample name: 40_162_DN3b


title: CLP_rep1 (23_122_CLP)

description:
p23_s122.cel
Sample name: 23_122_CLP
Re-analysis of GSM507378


title: DN4_rep3

description:
p41_s166.cel
Sample name: 41_166_DN4


title: CD8+ CD69-_rep3

description:
p47_s184.cel
Sample name: 47_184_CD8+ CD69-


title: DP CD69+_rep3

description:
p43_s172.cel
Sample name: 43_172_DP CD69+


title: DN4_rep2

description:
p41_s165.cel
Sample name: 41_165_DN4


title: CD4+ CD69-_rep2

description:
p45_s177.cel
Sample name: 45_177_CD4+ CD69-


title: CD8+ CD69-_rep1

description:
p47_s182.cel
Sample name: 47_182_CD8+ CD69-


title: DP CD69-_rep1

description:
p42_s167.cel
Sample name: 42_167_DP CD69-


title: DN3b_rep1

description:
p40_s161.cel
Sample name: 40_161_DN3b


title: mNK_rep1

description:
p36_s150.cel
Sample name: 36_150_mNK

source_name: Spleen

value: mNK

value: 3 months


title: DN4_rep1

description:
p41_s164.cel
Sample name: 41_164_DN4

value: male


title: iNK_rep2

description:
p35_s149.cel
Sample name: 35_149_iNK

source_name: bone marrow

value: iNK


title: mNK_rep2

description:
p36_s151.cel
Sample name: 36_151_mNK


title: iNK_rep1

description:
p35_s148.cel
Sample name: 35_148_iNK


title: FoB_rep2

description:
p34_s147.cel
Sample name: 34_147_FoB

value: FoB

value: 2-3 months


title: FoB_rep1

description:
p34_s146.cel
Sample name: 34_146_FoB


title: T2B_rep1

description:
p32_s142.cel
Sample name: 32_142_T2B


title: MzB_rep1

description:
p33_s144.cel
Sample name: 33_144_MzB

value: MzB


title: T2B_rep2

description:
p32_s143.cel
Sample name: 32_143_T2B


title: T1B_rep2

description:
p31_s141.cel
Sample name: 31_141_T1B


title: T1B_rep1

description:
p31_s140.cel
Sample name: 31_140_T1B


title: MzB_rep2

description:
p33_s145.cel
Sample name: 33_145_MzB


title: DP CD69-_rep2

description:
p42_s168.cel
Sample name: 42_168_DP CD69-


title: FrE_rep1

description:
p30_s138.cel
Sample name: 30_138_FrE

value: FrE


title: preproB_rep4

description:
p26_s131.cel
Sample name: 26_131_preproB

value: preproB


title: FcC_rep1

description:
p28_s134.cel
Sample name: 28_134_FrC

value: FrC


title: preproB_rep3

description:
p26_s130.cel
Sample name: 26_130_preproB


title: preproB_rep1

description:
p26_s128.cel
Sample name: 26_128_preproB


title: Mono_rep1

description:
p22_s120.cel
Sample name: 22_120_Mono

value: Mono


title: FrE_rep2

description:
p30_s139.cel
Sample name: 30_139_FrE


title: FcD_rep2

description:
p29_s137.cel
Sample name: 29_137_FrD

value: FrD


title: FcB_rep1

description:
p27_s132.cel
Sample name: 27_132_FrB

value: FrB


title: FcB_rep2

description:
p27_s133.cel
Sample name: 27_133_FrB


title: S288C-3

status: Public on Feb 09 2012

type: genomic

city: Montpellier cedex1

first: Jean-Luc

last: Legras

address: 2, place Viala

department: UMR1083, Science pour l'Oenologie

country: France

institute: INRA

description: reference strain

hyb_protocol: Winzeler (2003) Genetics

scan_protocol: Affymetrix scanner

data_processing: Calculation of hybridization of each gene has been calculated according Robust Multiaray Averaging  using affylmGUI package under R statistical environment. [log ratio was obtained for each gene for Eg8 in comparison to S288C and is provided as a Series supplementary file.]

molecule: genomic DNA

organism: Saccharomyces cerevisiae

label_protocol: Winzeler (2003) Genetics

growth_protocol: overnight YPD shaken culture 28C

extract_protocol: DNA extraction according to legras et al. 2003 FEMS microbiol letters.


title: S288C-1

description: reference strain


title: S288C-2

description: reference strain


title: FcC_rep2

description:
p28_s135.cel
Sample name: 28_135_FrC


title: Mono_rep2

description:
p22_s121.cel
Sample name: 22_121_Mono


title: FcD_rep1

description:
p29_s136.cel
Sample name: 29_136_FrD


title: preproB_rep2

description:
p26_s129.cel
Sample name: 26_129_preproB


title: U13-2

description: analyzed strains


title: U13-1

description: analyzed strains


title: Eg25-1

description: analyzed strains


title: Gra_rep2

description:
p21_s119.cel
Sample name: 21_119_Gra

value: Gra


title: V5-1

description: analyzed strains


title: Gra_rep1

description:
p21_s118.cel
Sample name: 21_118_Gra


title: Eg25-2

description: analyzed strains


title: Eg8-3

description: analyzed strains

organism: Saccharomyces cerevisiae x Saccharomyces kudriavzevii


title: Eg8-2

description: analyzed strains


title: V5-2

description: analyzed strains


title: H9_ES-1

status: Public on Sep 30 2010

first: Hu

last: Li

address: 3 Blackfan Circle

institute: Wyss Institute

description: Gene expression data obtained from human ES

hyb_protocol: cDNA was fragmented and 10ug hybridized to an Affymetrix U133 Plus 2.0 array for 16 hours. Arrays were washed and stained using the Affy 450 Fluidics Station according to the manufacturer's protocol

scan_protocol: Arrays were scanned using a GeneChip 3000 scanner according to the manufacturers recommendation

data_processing: RMA (Bioconductor Affy Package)

source_name: human ES

label_protocol: Preparation of biotinylated cDNA was performed according to the standard Nugen amplification sample preparation protocol, starting with 100ng of total RNA

growth_protocol: standard HESC growth conditions as described in Pick et al. (2009).

extract_protocol: Trizol isolation followed by Rneasy (Qiagen) column purification were performed according to manufacturer's specifications

value: H9 Human embryonic stem cells

tag: reprogramming protocol


title: H9_ES-2


title: BJ_Fibroblast_2

description: Gene expression data obtained from fibroblasts

source_name: fibroblast, untransfected

growth_protocol: Fibroblasts were grown in alpha-MEM containing 10 % inactivated fetal serum (IFS), 50 U/ml penicillin, 50 mg/ml streptomycin, and 1 mM L-glutamine. Replacement,10 ng/ml bFGF, 1 mM L-glutamine, 100 uM nonessential amino acids, 100 uM 2-mercaptoethanol, 50 U/ml penicillin, and 50 mg/ml streptomycin).

value: BJ fibroblast


title: H1_ES-1

value: H1 Human embryonic stem cells


title: dH1F_Fibroblast_2

value: dH1F fibroblast


title: dH1F_Fibroblast_1


title: H1_ES-2


title: BJ_Fibroblast_1


title: Gubernaculum_100nMInsulin-like3_biological rep6

status: Public on Jul 02 2010

city: Wilmington

first: Julia

last: Barthold

state: DE

address: 1600 Rockland Road

department: Urology

institute: Nemours/AI duPonst Hospital for Children

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
100_nM_Insl3-6

hyb_protocol: After fragmentation, 15 ug of cRNA was hybridized for 16 hr at 45C on GeneChip Rat Genome 230 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: Microarrays were scanned using an Affymetrix GeneChip Scanner 3000 7G.

data_processing: Summarized probeset data were generated with R/Bioconductor using the GC-RMA method.

organism: Rattus norvegicus

source_name: gubernaculum, cultured with 100 nM Insulin-like 3

label_protocol: Biotinylated cRNA were prepared from 150 ng total RNA using the Affymetrix GeneChip 3' IVT Express Kit according to the manufacturer's protocol.

growth_protocol: Using a stereomicroscope, fine scissors and fine forceps, gubernacula were microdissected by breaking the gubernaculum cord and cutting the gubernaculum bulb where it attached to the abdominal wall.  Immediately after microdissection, two gubernacula bulbs/biological replicate were cultured at an air/liquid interface by placing the tissues on Millicell CM culture inserts (0.4 micron pore size; catalog number PICM03050; Millipore Corp., Billerica, MA) in 6 well polystyrene culture plates (catalog number 3506; Corning Inc., Lowell, MA) containing 1 ml of medium/well.  All medium reagents were obtained from Invitrogen Corp. (Carlsbad, CA), and the recipe was DMEM/F12 (catalog number 21041-025), 2% charcoal stripped fetal bovine serum (catalog number 12676-011), 1X insulin-transferrin-selenium-x supplement (catalog number 51500-056), and 1X antibiotic-antimycotic (catalog number 15240-096).  Cultures were maintained at 37°C in a humidified chamber with a 5% carbon dioxide atmosphere.  Gubernacula were cultured in medium without Insl3 (control medium) for 24 hours.

extract_protocol: Gubernaculum total RNA was isolated using a Qiagen RNeasy Micro kit according to the manufacturer's instructions.  Gubernacula were scraped from the filter inserts using a pipet and a small amount of RLT buffer (supplied with the RNeasy kit).  Total RNA was eluted with 14 ml of water and stored at -80C until labeling for microarray analysis.

treatment_protocol: After microdissection, gubernacula were cultured for 24 hours in complete medium without any additional hormone and subsequently cultured for an additional 24 hours in medium with or without Insl3 (10 or 100 nM; catalog number 035-43, Phoenix Pharmaceuticals Inc., Burlingame, CA).

value: Long Evans

value: gubernaculum

value: 100nM insulin-like 3

value: gestational day 17

tag: rna integrity number (from agilent bioanalzyer 2100)

tag: biotin-labeled crna yield (ug)

tag: outlier?

value: No


title: Gubernaculum_100nMInsulin-like3_biological rep3

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
100_nM_Insl3-3

tag: tissue


title: Gubernaculum_100nMInsulin-like3_biological rep2

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
100_nM_Insl3-2

tag: treatment


title: Gubernaculum_control_biological rep3

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
Control-3

source_name: gubernaculum, cultured without Insulin-like 3


title: Gubernaculum_10nMInsulin-like3_biological rep4

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
10_nM_Insl3-4

source_name: gubernaculum, cultured with 10 nM Insulin-like 3

value: 10nM insulin-like 3

value: Yes


title: Gubernaculum_control_biological rep4

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
Control-4


title: Gubernaculum_100nMInsulin-like3_biological rep1

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
100_nM_Insl3-1


title: Gubernaculum_control_biological rep6

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
Control-6


title: Gubernaculum_100nMInsulin-like3_biological rep5

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
100_nM_Insl3-5


title: Gubernaculum_10nMInsulin-like3_biological rep5

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
10_nM_Insl3-5


title: Gubernaculum_10nMInsulin-like3_biological rep2

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
10_nM_Insl3-2

value: Not determined


title: MPP_FLneg_rep2

status: Public on Aug 15 2010

data_processing: The data were analyzed with R/Bioconductor.

tag: progenitor population

value: MMPFL-

value: 2 month

tag: gender

value: male


title: Gubernaculum_10nMInsulin-like3_biological rep1

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
10_nM_Insl3-1

tag: strain

tag: age


title: MPP_FLneg_rep3


title: MPP_FLneg_rep5


title: MPP_FLneg_rep4


title: Gubernaculum_control_biological rep2

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
Control-2


title: Gubernaculum_100nMInsulin-like3_biological rep4

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
100_nM_Insl3-4


title: MPP_FLneg_rep1


title: Gubernaculum_10nMInsulin-like3_biological rep3

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
10_nM_Insl3-3


title: Gubernaculum_control_biological rep5

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
Control-5


title: Gubernaculum_control_biological rep1

description:
Gubernaculum dissected on gestational day 17; day when dam was sperm positive = gestational day 0.
Control-1